Our global life sciences company brings diagnostic testing & drug development together. Explore what we do.
Litholink is committed to remaining at the forefront of laboratory testing for patients with urolithiasis through continuous development in scientific research, assay development, and updating our interpretive software as the diagnosis and treatment of patients with urolithiasis evolves. Litholink collaborates with leading researchers all over the country in order to advance the field of urolithiasis research. Over the past 20+ years, Litholink has contributed to over 100 published peer-reviewed studies.